Articles liés à Biomarkers for Alzheimer's Disease Drug Development

Biomarkers for Alzheimer's Disease Drug Development - Couverture rigide

 
9781071637739: Biomarkers for Alzheimer's Disease Drug Development

Synopsis

This fully updated volume provides an up-to-date and comprehensive overview of the current state of technologies helping to accelerate Alzheimer’s disease drug development. Addressing the latest advances in preclinical and clinical research, including new insights into the molecular mechanisms and emerging therapeutic strategies, the book continues by exploring digital biomarkers and advanced neuroimaging analysis which will transform how clinical trials in the Alzheimer’s disease field are performed. Written for the highly successful Methods in Molecular Biology series, chapters feature the kind of detailed implementation advice that leads to greater success in the lab or clinic. 
Authoritative and practical, Biomarkers for Alzheimer’s Disease Drug Development, Second Edition seeks to inspire and inform future efforts to develop effective treatments for this devastating disease.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Acheter neuf

Afficher cet article
EUR 149,85

Autre devise

EUR 48,99 expédition depuis Allemagne vers Etats-Unis

Destinations, frais et délais

Autres éditions populaires du même titre

9781071637760: Biomarkers for Alzheimer’s Disease Drug Development

Edition présentée

ISBN 10 :  1071637762 ISBN 13 :  9781071637760
Editeur : Humana, 2025
Couverture souple

Résultats de recherche pour Biomarkers for Alzheimer's Disease Drug Development

Image fournie par le vendeur

Edité par Springer US, 2024
ISBN 10 : 1071637738 ISBN 13 : 9781071637739
Neuf Couverture rigide
impression à la demande

Vendeur : moluna, Greven, Allemagne

Évaluation du vendeur 4 sur 5 étoiles Evaluation 4 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Includes cutting-edge techniquesProvides step-by-step detail essential for reproducible resultsContains key implementation advice from the expertsThis fully updated volume provides an up-to-date and comprehensive overview of the cur. N° de réf. du vendeur 1303459455

Contacter le vendeur

Acheter neuf

EUR 149,85
Autre devise
Frais de port : EUR 48,99
De Allemagne vers Etats-Unis
Destinations, frais et délais

Quantité disponible : Plus de 20 disponibles

Ajouter au panier

Image fournie par le vendeur

Robert Perneczky
ISBN 10 : 1071637738 ISBN 13 : 9781071637739
Neuf Couverture rigide
impression à la demande

Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This fully updated volume provides an up-to-date and comprehensive overview of the current state of technologies helping to accelerate Alzheimer's disease drug development. Addressing the latest advances in preclinical and clinical research, including new insights into the molecular mechanisms and emerging therapeutic strategies, the book continues by exploring digital biomarkers and advanced neuroimaging analysis which will transform how clinical trials in the Alzheimer's disease field are performed. Written for the highly successful Methods in Molecular Biology series, chapters feature the kind of detailed implementation advice that leads to greater success in the lab or clinic.Authoritative and practical, Biomarkers for Alzheimer's Disease Drug Development, Second Edition seeks to inspire and inform future efforts to develop effective treatments for this devastating disease. 347 pp. Englisch. N° de réf. du vendeur 9781071637739

Contacter le vendeur

Acheter neuf

EUR 181,89
Autre devise
Frais de port : EUR 23
De Allemagne vers Etats-Unis
Destinations, frais et délais

Quantité disponible : 2 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Robert Perneczky
ISBN 10 : 1071637738 ISBN 13 : 9781071637739
Neuf Couverture rigide

Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Buch. Etat : Neu. Neuware -This fully updated volume provides an up-to-date and comprehensive overview of the current state of technologies helping to accelerate Alzheimer¿s disease drug development. Addressing the latest advances in preclinical and clinical research, including new insights into the molecular mechanisms and emerging therapeutic strategies, the book continues by exploring digital biomarkers and advanced neuroimaging analysis which will transform how clinical trials in the Alzheimer¿s disease field are performed. Written for the highly successful Methods in Molecular Biology series, chapters feature the kind of detailed implementation advice that leads to greater success in the lab or clinic.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 364 pp. Englisch. N° de réf. du vendeur 9781071637739

Contacter le vendeur

Acheter neuf

EUR 181,89
Autre devise
Frais de port : EUR 60
De Allemagne vers Etats-Unis
Destinations, frais et délais

Quantité disponible : 2 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Robert Perneczky
Edité par Springer US, Springer US, 2024
ISBN 10 : 1071637738 ISBN 13 : 9781071637739
Neuf Couverture rigide

Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - This fully updated volume provides an up-to-date and comprehensive overview of the current state of technologies helping to accelerate Alzheimer's disease drug development. Addressing the latest advances in preclinical and clinical research, including new insights into the molecular mechanisms and emerging therapeutic strategies, the book continues by exploring digital biomarkers and advanced neuroimaging analysis which will transform how clinical trials in the Alzheimer's disease field are performed. Written for the highly successful Methods in Molecular Biology series, chapters feature the kind of detailed implementation advice that leads to greater success in the lab or clinic.Authoritative and practical, Biomarkers for Alzheimer's Disease Drug Development, Second Edition seeks to inspire and inform future efforts to develop effective treatments for this devastating disease. N° de réf. du vendeur 9781071637739

Contacter le vendeur

Acheter neuf

EUR 185,68
Autre devise
Frais de port : EUR 64,41
De Allemagne vers Etats-Unis
Destinations, frais et délais

Quantité disponible : 1 disponible(s)

Ajouter au panier